The Supreme Court on Friday refused to pass any interim order on pleas relating to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters and hospital operators — Malvinder and Shivinder Singh. A bench comprising Chief Justice Ranjan Gogoi and Justice Sanjiv Khanna said that it give the case a final hearing February 26.

The apex court was hearing the plea of Japanese firm Daiichi Sankyo which is seeking to recover ₹3,500 crore, awarded to it by a Singapore tribunal in its case against Malvinder and Shivinder Singh.

The Japanese firm, which has filed the contempt plea against the Singh brothers in the apex court, has said that it was promised some shares of Fortis Healthcare by the Singh brothers.

“Instead of passing any order on the interlocutory applications, we fix the matter for final disposal on February 26 at the top of the Board,” the bench said.

The apex court, on December 14 last year, had ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare.

“Status quo with regard to sale of the controlling stake in Fortis Healthcare to Malaysian IHH Healthcare Berhad be maintained,” the bench had said.

The top court had also issued notices to the Singh brothers asking them to explain as to why contempt proceedings be not initiated against them for allegedly violating its earlier order by pledging the shares.

The board of Fortis Healthcare had approved in July a proposal from IHH Healthcare to invest ₹4,000 crore by way of preferential allotment for a 31.1 per cent stake.

The Malaysian IHH Healthcare Bhd became the controlling shareholder of Fortis Healthcare Ltd by acquiring a 31.1 per cent stake in the company.

Related Topics
comment COMMENT NOW